HIGHLIGHTS
- who: Patrick Kirchweger et al. from the George Washington University, United States have published the paper: Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the correlation between the change of ctDNA levels and response to treatment in patients treated by systemic therapy. This study shows that continuous detection of ctDNA levels during systemic treatment is feasible and could be beneficial for patients by potentially sparing insufficient cytotoxic treatments for 10-12 weeks if compared to treatment reevaluation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.